{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:43:47Z","timestamp":1783683827513,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.det.2010.02.003","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T07:18:40Z","timestamp":1273043920000},"page":"361-366","source":"Crossref","is-referenced-by-count":12,"title":["Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"28","author":[{"given":"Matthias","family":"Titeux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Pendaries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2010.02.003_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.det.2010.02.003_bib2","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1073\/pnas.84.8.2302","article-title":"Three clonal types of keratinocyte with different capacities for multiplication","volume":"84","author":"Barrandon","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.det.2010.02.003_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(75)80001-8","article-title":"Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells","volume":"6","author":"Rheinwald","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.det.2010.02.003_bib4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00007890-200012150-00009","article-title":"Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix","volume":"70","author":"Ronfard","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.det.2010.02.003_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.TP.0000112381.80964.85","article-title":"Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin","volume":"77","author":"Llames","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.det.2010.02.003_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0167-7799(00)88913-1","article-title":"Culturing skin in vitro for wound therapy","volume":"13","author":"Navsaria","year":"1995","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.det.2010.02.003_bib7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1089\/10430340260201743","article-title":"A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line","volume":"13","author":"Mecklenbeck","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.det.2010.02.003_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm766","article-title":"Stable nonviral genetic correction of inherited human skin disease","volume":"8","author":"Ortiz-Urda","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.det.2010.02.003_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng1041","article-title":"Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa","volume":"32","author":"Chen","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2010.02.003_bib10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2010.02.003_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.jid.5700117","article-title":"Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa","volume":"126","author":"Goto","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2010.02.003_bib12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/hum.2004.15.921","article-title":"Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa","volume":"15","author":"Gache","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.det.2010.02.003_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI200317193","article-title":"Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue","volume":"111","author":"Ortiz-Urda","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.det.2010.02.003_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1063","article-title":"Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa","volume":"10","author":"Woodley","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.det.2010.02.003_bib15","first-page":"110","article-title":"Ex vivo gene therapy for recessive dystrophic epidermolysis bullosa using safe retroviral vectors expressing type VII collagen under the control of its promoter","volume":"125","author":"Titeux","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2010.02.003_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ymthe.2004.05.016","article-title":"Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo","volume":"10","author":"Woodley","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.det.2010.02.003_bib17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.gt.3302354","article-title":"Gene therapy progress and prospects: bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment","volume":"11","author":"Spink","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.det.2010.02.003_bib18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1261\/rna.653607","article-title":"Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications","volume":"13","author":"Aartsma-Rus","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.det.2010.02.003_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.det.2010.02.003_bib20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2010.02.003_bib21","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","article-title":"Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients","volume":"126","author":"Goto","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2010.02.003_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2010.02.003_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal t cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.det.2010.02.003_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/mt.2008.238","article-title":"Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance","volume":"17","author":"Cornils","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.det.2010.02.003_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/mt.2009.51","article-title":"Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design","volume":"17","author":"Maruggi","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.det.2010.02.003_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.det.2010.02.003_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2007.03.006","article-title":"Immune response against therapeutic factor VIII in hemophilia A patients\u2014a survey of probable risk factors","volume":"110","author":"Dasgupta","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.det.2010.02.003_bib28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.gt.3302539","article-title":"Major role of local immune responses in antibody formation to factor IX in AAV gene transfer","volume":"12","author":"Wang","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.det.2010.02.003_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1525-0016(03)00013-3","article-title":"Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy","volume":"7","author":"Ghazizadeh","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.det.2010.02.003_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm0596-545","article-title":"Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors","volume":"2","author":"Tripathy","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.det.2010.02.003_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-007-0027-6","article-title":"Autoimmunity to type VII collagen: epidermolysis bullosa acquisita","volume":"33","author":"Woodley","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.det.2010.02.003_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0733-8635(18)30458-3","article-title":"Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen","volume":"8","author":"Woodley","year":"1990","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2010.02.003_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","article-title":"Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa","volume":"17","author":"Remington","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.det.2010.02.003_bib34","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(04)16154-0","article-title":"Autoantibodies as predictors of disease","volume":"363","author":"Scofield","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.det.2010.02.003_bib35","doi-asserted-by":"crossref","unstructured":"Pendaries V, Gasc G, Titeux M, et al. Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa. Gene Therapy 2010, in press.","DOI":"10.1038\/gt.2010.36"},{"key":"10.1016\/j.det.2010.02.003_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17402520600876804","article-title":"Oral tolerance: therapeutic implications for autoimmune diseases","volume":"13","author":"Faria","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.det.2010.02.003_bib37","first-page":"558","article-title":"Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors","volume":"91","author":"Rocino","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.det.2010.02.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2009.03069.x","article-title":"The companions: regulatory T cells and gene therapy","volume":"127","author":"Eghtesad","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.det.2010.02.003_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of\u00a0acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.det.2010.02.003_bib40","doi-asserted-by":"crossref","unstructured":"Titeux M, Pendaries V, Zanta-Boussif MA, et al. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 2010, in press.","DOI":"10.1038\/mt.2010.91"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:49:08Z","timestamp":1559072948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0733863510000197"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.02.003","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}